 | • レポートコード：MRC2304A198 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、227ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に1,759.45百万ドルであった世界の頭蓋顎顔面用デバイス市場規模が2022年に1,933.11百万ドルに到達し、2027年までにCAGR 10.04％で成長して3,124.99百万ドルへと拡大すると予測しています。当調査資料では、頭蓋顎顔面用デバイスの世界市場について多角的な視点から分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、インプラント種類別（カスタマイズ/患者固有インプラント、標準インプラント）分析、治療別（骨移植代用品、CMF延長術、CMFプレート＆ネジ固定術、頭蓋弁固定術、顎関節置換術）分析、材料別（生体吸収性素材、セラミックス、金属＆合金）分析、エンドユーザー別（外来手術センター、美容外科医、病院、外科医）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめました。なお、当書内の企業情報としては、Antibe Therapeutics Inc.、B. Braun Melsungen AG、CONMED Corporation、DePuy Synthes、General Electric Company、Integra LifeSciences Pvt Ltd.、Invibio Ltd.、KLS Martin Group、Matrix Surgical USA、Medartis AG、Medtronic Pvt. Ltd、Stryker Corporationなどが掲載されています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の頭蓋顎顔面用デバイス市場規模：インプラント種類別 - カスタマイズ/患者固有インプラントの市場規模 - 標準インプラントの市場規模 ・世界の頭蓋顎顔面用デバイス市場規模：治療別 - 骨移植代用品の市場規模 - CMF延長術の市場規模 - CMFプレート＆ネジ固定術の市場規模 - 頭蓋弁固定術の市場規模 - 顎関節置換術の市場規模 ・世界の頭蓋顎顔面用デバイス市場規模：材料別 - 生体吸収性素材の市場規模 - セラミックスの市場規模 - 金属＆合金の市場規模 ・世界の頭蓋顎顔面用デバイス市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 美容外科医における市場規模 - 病院における市場規模 - 外科医における市場規模 ・世界の頭蓋顎顔面用デバイス市場規模：地域別 - 南北アメリカの頭蓋顎顔面用デバイス市場規模 アメリカの頭蓋顎顔面用デバイス市場規模 カナダの頭蓋顎顔面用デバイス市場規模 ブラジルの頭蓋顎顔面用デバイス市場規模 ... - アジア太平洋の頭蓋顎顔面用デバイス市場規模 日本の頭蓋顎顔面用デバイス市場規模 中国の頭蓋顎顔面用デバイス市場規模 インドの頭蓋顎顔面用デバイス市場規模 韓国の頭蓋顎顔面用デバイス市場規模 台湾の頭蓋顎顔面用デバイス市場規模 ... - ヨーロッパ/中東/アフリカの頭蓋顎顔面用デバイス市場規模 イギリスの頭蓋顎顔面用デバイス市場規模 ドイツの頭蓋顎顔面用デバイス市場規模 フランスの頭蓋顎顔面用デバイス市場規模 ロシアの頭蓋顎顔面用デバイス市場規模 ... - その他地域の頭蓋顎顔面用デバイス市場規模 ・競争状況 ・企業情報 |
The Global Craniomaxillofacial Devices Market size was estimated at USD 1,759.45 million in 2021 and expected to reach USD 1,933.11 million in 2022, and is projected to grow at a CAGR 10.04% to reach USD 3,124.99 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Craniomaxillofacial Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Implant Type, the market was studied across Customized/Patient-specific Implants and Standard Implants.
Based on Treatment, the market was studied across Bone Graft Substitute, CMF Distraction, CMF Plate and Screw Fixation, Cranial Flap Fixation, Temporomandibular Joint Replacement, and Thoracic Fixation.
Based on Material, the market was studied across Bioabsorbable material, Ceramics, and Metal and Alloys.
Based on Location, the market was studied across External Fixators and Internal Fixators.
Based on End Users, the market was studied across Ambulatory Surgery Centres, Cosmetic surgeons, Hospitals, and Surgeons.
Based on Application, the market was studied across Neurosurgery & ENT, Orthognathic and Dental Surgery, and Plastic surgery.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Craniomaxillofacial Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Craniomaxillofacial Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Craniomaxillofacial Devices Market, including Antibe Therapeutics Inc., B. Braun Melsungen AG, CONMED Corporation, DePuy Synthes, General Electric Company, Integra LifeSciences Pvt Ltd., Invibio Ltd., KLS Martin Group, Matrix Surgical USA, Medartis AG, Medtronic Pvt. Ltd, Stryker Corporation, Summit Medical Group, TMJ Concepts, and Zimmer Biomet Holding Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Craniomaxillofacial Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Craniomaxillofacial Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Craniomaxillofacial Devices Market?
4. What is the competitive strategic window for opportunities in the Global Craniomaxillofacial Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Craniomaxillofacial Devices Market?
6. What is the market share of the leading vendors in the Global Craniomaxillofacial Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Craniomaxillofacial Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High preference for minimally invasive surgeries
5.1.1.2. Rising cases of facial and head injuries caused due to sports-related injuries and road accidents
5.1.1.3. Increasing modernization in the healthcare sector
5.1.2. Restraints
5.1.2.1. High cost of the devices
5.1.3. Opportunities
5.1.3.1. Innovations and technologically advanced products
5.1.3.2. Surge in investments by the health care facilities and the manufacturers
5.1.3.3. Growth in research and development activities
5.1.4. Challenges
5.1.4.1. Low healthcare infrastructure rates in the developing economies
5.2. Cumulative Impact of COVID-19
6. Craniomaxillofacial Devices Market, by Implant Type
6.1. Introduction
6.2. Customized/Patient-specific Implants
6.3. Standard Implants
7. Craniomaxillofacial Devices Market, by Treatment
7.1. Introduction
7.2. Bone Graft Substitute
7.3. CMF Distraction
7.4. CMF Plate and Screw Fixation
7.5. Cranial Flap Fixation
7.6. Temporomandibular Joint Replacement
7.7. Thoracic Fixation
8. Craniomaxillofacial Devices Market, by Material
8.1. Introduction
8.2. Bioabsorbable material
8.3. Ceramics
8.4. Metal and Alloys
9. Craniomaxillofacial Devices Market, by Location
9.1. Introduction
9.2. External Fixators
9.3. Internal Fixators
10. Craniomaxillofacial Devices Market, by End Users
10.1. Introduction
10.2. Ambulatory Surgery Centres
10.3. Cosmetic surgeons
10.4. Hospitals
10.5. Surgeons
11. Craniomaxillofacial Devices Market, by Application
11.1. Introduction
11.2. Neurosurgery & ENT
11.3. Orthognathic and Dental Surgery
11.4. Plastic surgery
12. Americas Craniomaxillofacial Devices Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Craniomaxillofacial Devices Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Craniomaxillofacial Devices Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Antibe Therapeutics Inc.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. B. Braun Melsungen AG
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. CONMED Corporation
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. DePuy Synthes
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. General Electric Company
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Integra LifeSciences Pvt Ltd.
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Invibio Ltd.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. KLS Martin Group
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Matrix Surgical USA
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Medartis AG
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Medtronic Pvt. Ltd
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Stryker Corporation
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Summit Medical Group
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. TMJ Concepts
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Zimmer Biomet Holding Inc
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing